Cipla Limited (CIPLA) - Total Liabilities
Based on the latest financial reports, Cipla Limited (CIPLA) has total liabilities worth Rs71.39 Billion INR (≈ $772.10 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cipla Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Cipla Limited's total liabilities have evolved over time, based on quarterly financial data. See Cipla Limited (CIPLA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Cipla Limited Competitors by Total Liabilities
The table below lists competitors of Cipla Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hasbro Inc
NASDAQ:HAS
|
USA | $5.26 Billion |
|
American Homes 4 Rent
NYSE:AMH
|
USA | $5.42 Billion |
|
HF Sinclair Corp
NYSE:DINO
|
USA | $8.44 Billion |
|
Embraer SA ADR
NYSE:ERJ
|
USA | $8.59 Billion |
|
Saputo Inc
TO:SAP
|
Canada | CA$6.80 Billion |
|
McCormick & Company Incorporated
NYSE:MKC
|
USA | $8.79 Billion |
|
Kuang Chi Technologies Co Ltd
SHE:002625
|
China | CN¥1.83 Billion |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
USA | $2.42 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Cipla Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CIPLA stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.13 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cipla Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cipla Limited (2004–2025)
The table below shows the annual total liabilities of Cipla Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs60.98 Billion ≈ $659.45 Million |
+3.09% |
| 2024-03-31 | Rs59.15 Billion ≈ $639.72 Million |
+2.88% |
| 2023-03-31 | Rs57.50 Billion ≈ $621.81 Million |
-3.91% |
| 2022-03-31 | Rs59.84 Billion ≈ $647.12 Million |
-8.87% |
| 2021-03-31 | Rs65.66 Billion ≈ $710.12 Million |
-13.66% |
| 2020-03-31 | Rs76.05 Billion ≈ $822.48 Million |
-11.76% |
| 2019-03-31 | Rs86.19 Billion ≈ $932.12 Million |
+4.11% |
| 2018-03-31 | Rs82.79 Billion ≈ $895.33 Million |
+2.78% |
| 2017-03-31 | Rs80.55 Billion ≈ $871.14 Million |
-13.03% |
| 2016-03-31 | Rs92.62 Billion ≈ $1.00 Billion |
+95.58% |
| 2015-03-31 | Rs47.36 Billion ≈ $512.13 Million |
0.00% |
| 2014-03-31 | Rs47.36 Billion ≈ $512.13 Million |
+79.37% |
| 2013-03-31 | Rs26.40 Billion ≈ $285.52 Million |
+54.27% |
| 2012-03-31 | Rs17.11 Billion ≈ $185.07 Million |
-12.87% |
| 2011-03-31 | Rs19.64 Billion ≈ $212.41 Million |
+40.44% |
| 2010-03-31 | Rs13.99 Billion ≈ $151.25 Million |
-44.26% |
| 2009-03-31 | Rs25.09 Billion ≈ $271.34 Million |
+26.88% |
| 2008-03-31 | Rs19.77 Billion ≈ $213.85 Million |
+67.94% |
| 2007-03-31 | Rs11.77 Billion ≈ $127.34 Million |
-20.18% |
| 2006-03-31 | Rs14.75 Billion ≈ $159.52 Million |
+39.34% |
| 2005-03-31 | Rs10.59 Billion ≈ $114.48 Million |
+10.72% |
| 2004-03-31 | Rs9.56 Billion ≈ $103.40 Million |
-- |
About Cipla Limited
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, suc… Read more